Terms: = Skin cancer AND PTPN11, CFC, Q06124, 5781, ENSG00000179295, SHP2, MGC14433, SHP-2, BPTP3, PTP-1D, SH-PTP3, NS1, SH-PTP2, PTP2C AND Treatment
20 results:
1. Exogenous recombinant N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) inhibits progression of B16F10 cutaneous melanomas and modulates cell signaling.
Bhattacharyya S; O-Sullivan I; Tu J; Chen Z; Tobacman JK
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166913. PubMed ID: 37813168
[TBL] [Abstract] [Full Text] [Related]
2. Tumor Cell-Autonomous shp2 Contributes to Immune Suppression in Metastatic Breast cancer.
Chen H; Cresswell GM; Libring S; Ayers MG; Miao J; Zhang ZY; Solorio L; Ratliff TL; Wendt MK
Cancer Res Commun; 2022 Oct; 2(10):1104-1118. PubMed ID: 36969745
[TBL] [Abstract] [Full Text] [Related]
3. Influenza virus vector ins1 expressing bovine papillomavirus 1 (BPV1) antigens efficiently induces tumour regression in equine sarcoid patients.
Jindra C; Hainisch EK; Rümmele A; Wolschek M; Muster T; Brandt S
PLoS One; 2021; 16(11):e0260155. PubMed ID: 34797850
[TBL] [Abstract] [Full Text] [Related]
4. Genomic data from NSCLC tumors reveals correlation between shp-2 activity and PD-L1 expression and suggests synergy in combining shp-2 and PD-1/PD-L1 inhibitors.
Toral KJ; Wuenschel MA; Black EP
PLoS One; 2021; 16(8):e0256416. PubMed ID: 34437586
[TBL] [Abstract] [Full Text] [Related]
5. The glucocorticoids prednisone and dexamethasone differentially modulate T cell function in response to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade.
Okoye IS; Xu L; Walker J; Elahi S
Cancer Immunol Immunother; 2020 Aug; 69(8):1423-1436. PubMed ID: 32246174
[TBL] [Abstract] [Full Text] [Related]
6. Trametinib for progressive pediatric low-grade gliomas.
Kondyli M; Larouche V; Saint-Martin C; Ellezam B; Pouliot L; Sinnett D; Legault G; Crevier L; Weil A; Farmer JP; Jabado N; Perreault S
J Neurooncol; 2018 Nov; 140(2):435-444. PubMed ID: 30097824
[TBL] [Abstract] [Full Text] [Related]
7. The use of a sunscreen containing DNA-photolyase in the treatment of patients with field cancerization and multiple actinic keratoses: a case-series.
Navarrete-Dechent C; Molgó M
Dermatol Online J; 2017 Jan; 23(1):. PubMed ID: 28329483
[TBL] [Abstract] [Full Text] [Related]
8. Mechanism of melanoma cells selective apoptosis induced by a photoactive NADPH analogue.
Rouaud F; Boucher JL; Slama-Schwok A; Rocchi S
Oncotarget; 2016 Dec; 7(50):82804-82819. PubMed ID: 27756874
[TBL] [Abstract] [Full Text] [Related]
9. shp2 phosphatase as a novel therapeutic target for melanoma treatment.
Zhang RY; Yu ZH; Zeng L; Zhang S; Bai Y; Miao J; Chen L; Xie J; Zhang ZY
Oncotarget; 2016 Nov; 7(45):73817-73829. PubMed ID: 27650545
[TBL] [Abstract] [Full Text] [Related]
10. MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.
Toll A; Salgado R; Espinet B; Díaz-Lagares A; Hernández-Ruiz E; Andrades E; Sandoval J; Esteller M; Pujol RM; Hernández-Muñoz I
Mol Cancer; 2016 Jul; 15(1):53. PubMed ID: 27457246
[TBL] [Abstract] [Full Text] [Related]
11. Role of CPI-17 in restoring skin homoeostasis in cutaneous field of cancerization: effects of topical application of a film-forming medical device containing photolyase and UV filters.
Puig-Butillé JA; Malvehy J; Potrony M; Trullas C; Garcia-García F; Dopazo J; Puig S
Exp Dermatol; 2013 Jul; 22(7):494-6. PubMed ID: 23800065
[TBL] [Abstract] [Full Text] [Related]
12. Confirmation of skin doses resulting from bolus effect of intervening alpha-cradle and carbon fiber couch in radiotherapy.
Chan MF; Chiu-Tsao ST; Li J; Schupak K; Parhar P; Burman C
Technol Cancer Res Treat; 2012 Dec; 11(6):571-81. PubMed ID: 22712603
[TBL] [Abstract] [Full Text] [Related]
13. Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1.
Moehler M; Sieben M; Roth S; Springsguth F; Leuchs B; Zeidler M; Dinsart C; Rommelaere J; Galle PR
BMC Cancer; 2011 Oct; 11():464. PubMed ID: 22029859
[TBL] [Abstract] [Full Text] [Related]
14. MEK1 mutations confer resistance to MEK and B-RAF inhibition.
Emery CM; Vijayendran KG; Zipser MC; Sawyer AM; Niu L; Kim JJ; Hatton C; Chopra R; Oberholzer PA; Karpova MB; MacConaill LE; Zhang J; Gray NS; Sellers WR; Dummer R; Garraway LA
Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20411-6. PubMed ID: 19915144
[TBL] [Abstract] [Full Text] [Related]
15. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Vaijayanthi P; Krishnakumar S
Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
[TBL] [Abstract] [Full Text] [Related]
16. Anticancer activity of sodium stibogluconate in synergy with IFNs.
Yi T; Pathak MK; Lindner DJ; Ketterer ME; Farver C; Borden EC
J Immunol; 2002 Nov; 169(10):5978-85. PubMed ID: 12421984
[TBL] [Abstract] [Full Text] [Related]
17. A genetically engineered influenza A virus with ras-dependent oncolytic properties.
Bergmann M; Romirer I; Sachet M; Fleischhacker R; García-Sastre A; Palese P; Wolff K; Pehamberger H; Jakesz R; Muster T
Cancer Res; 2001 Nov; 61(22):8188-93. PubMed ID: 11719449
[TBL] [Abstract] [Full Text] [Related]
18. Vitalethine modulates erythropoiesis and neoplasia.
Knight GD; Laubscher KH; Fore ML; Clark DA; Scallen TJ
Cancer Res; 1994 Nov; 54(21):5623-35. PubMed ID: 7923208
[TBL] [Abstract] [Full Text] [Related]
19. Monoclonal antibody against human tyrosinase and reactive with melanotic and amelanotic melanoma cells.
McEwan M; Parsons PG; Moss DJ
J Invest Dermatol; 1988 Apr; 90(4):515-9. PubMed ID: 3127479
[TBL] [Abstract] [Full Text] [Related]
20. Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens.
Young DA; Prout GR; Lin CW
Cancer Res; 1985 Sep; 45(9):4439-46. PubMed ID: 3896480
[TBL] [Abstract] [Full Text] [Related]
